title: Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.
authors.forename: S N
authors.initials: SN
authors.lastname: Nikas
authors.forename: P V
authors.initials: PV
authors.lastname: Voulgari
authors.forename: I P
authors.initials: IP
authors.lastname: Takalou
authors.forename: P
authors.initials: P
authors.lastname: Katsimbri
authors.forename: A A
authors.initials: AA
authors.lastname: Drosos
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab